From BioHealth Investors
Biotechnology
INSMED INC [INSM] +13.87%
BIODELIVERY SCI INTL [BDSI] +8.86%
FAVRILLE, INC. [FVRL] +5.81%
VERNALIS PLC ADR [VNLS] +5.51%
SGX PHARMACEUTICALS [SGXP] +5.05%
Diagnostic Substances
RG GLBL LIFESTYLS [RGBL.OB] +20.54%
GENE LOGIC INC [GLGC] +10.34%
HEALTHCARE TECH LTD [HCTL] +7.14%
PALATIN TECH INC [PTN] +2.96%
THRESHOLD PHARMACEUT [THLD] +2.05%
Drug Delivery
INSITE VISION INC [ISV] +3.36%
IOMED INC [IOX] +1.72%
NEKTAR THERAPEUTIC [NKTR] +1.28%
SKYEPHARMA PLC [SKYE] +0.95%
Drug Manufacturers
TAPESTRY PHARMA INC [TPPH] +6.45%
NITROMED, INC. [NTMD] +5.85%
SUPERGEN INC [SUPG] +4.77%
ALTAIR NANOTECH INC [ALTI] +4.48%
ELITE PHARMA INC [ELI] +2.94%
Medical Appliances & Equipment
DYNATRONICS CP [DYNT] +9.52%
RESTORE MEDICAL INC [REST] +7.95%
MEDICALCV INC [MCVI.OB] +7.50%
CELSION CORP [CLN] +6.98%
TRIMEDYNE INC [TMED.OB] +4.73%
Medical Instruments & Supplies
CRYOCOR, INC. [CRYO] +21.59%
MILESTONE SCIENTIFIC [MLSS.OB] +15.38%
AMDL, INC [ADL] +6.12%
CANTEL MEDICAL CORP [CMN] +4.36%
LEMAITRE VASCULAR [LMAT] +3.33%
Medical Laboratories & Research
SPHERIX INC [SPEX] +4.27%
ERESEARCHTECHNOLOG [ERES] +0.71%
ARRAY BIOPHARMA IN [ARRY] +0.68%
PSYCHEMEDICS NEW [PMD] +0.30%
MEDTOX SCIENTFIC INC [MTOX] +0.15%
http://www.biohealthinvestor.com/
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
